• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

The role of free fatty acids in the pathogenesis of insulin resistance and diabetes mellitus -13C/31P - NMR studies

The role of free fatty acids in the pathogenesis of insulin resistance and diabetes mellitus -13C/31P - NMR studies

Michael Roden (ORCID: )
  • Grant DOI 10.55776/P13213
  • Funding program Principal Investigator Projects
  • Status ended
  • Start January 1, 1999
  • End July 31, 2001
  • Funding amount € 202,673

Disciplines

Clinical Medicine (70%); Medical Engineering (30%)

Keywords

    FREIE FETTSÄUREN, IN VIVO NMR SPEKTROSKOPIE, INSULIN, LEBER, GLUKOSE, SKELETTMUSKEL

Abstract Final report

Free fatty acids (FFA) play a pivotal role in the pathogenesis of insulin resistance since elevation of plasma FFA concentrations is not only associated with human obesity but may also preceed the manifestation of type II diabetes mellitus independently of body weight and hyperlipidemia. Despite the classical in vitro studies of Randle and co- workers, the interaction between FFA and glucose metabolism and particularly the mechanism by which FFA induce insulin resistance at level of the liver and skeletal muscle is still under debate. Prior to the advent of in vivo NMR spectroscopy, studies on human glucose metabolism were limited to tracer experiments and/or determination of glycogen and glucose metabolites in biopsies. By using non-invasive in vivo 13C and 31P NMR spectroscopy we have recently reported that - in contrast to the Randle hypothesis FFA decrease insulin-dependent glucose disposal which is associated with a blunted increase of intramyocellular glucose-6-phosphate and with reduction in rates of glucose oxidation and glycogen synthesis in human calf muscle. This proposal aims at further localization along the metabolic pathway in vivo of free fatty acid interaction with glucose metabolism both at the level of glucose transport, glucose phosphorylation, and glycogen synthesis. To this end, intracellular steps of metabolic pathways will be traced in liver as well as skeletal muscle employing NMR spectroscopy in man. In detail, the foreseen experiments will examine: (I) the primary (early) action of free fatty acids on the time course and concentration-dependent changes of intramyocellular g6p concentrations, (II) the effect of free fatty acids on intramyocellular free glucose concentration and glycogen synthesis, and intramyocellular triglyceride concentration, and (III) the effects of free fatty acid elevation on hepatic glucose production and gluconeogenesis in vivo in healthy subjects, offspring of and patients with overt type II diabetes mellitus. Preliminary results of Protocol 1 demonstrate a lack of an initial peak along with a rapid decline of muscle glucose-6-phosphate concentrations even at fasting plasma FFA levels, suggesting that FFA primarily cause a defect of glucose transport/phosphorylation under physiological conditions in man.

Background: Obesity and fat-rich diets increase the blood concentrations of free fatty acids. Free fatty acids are considered to impair insulin action, i.e. to induce insulin resistance, which relates to the development of the frequent type of diabetes mellitus (type 2 diabetes) and to premature vascular defects (myocardial infarction, stroke). Aims: How free fatty acids affect insulin action and in particular glucose metabolism in cells of the human body is still unclear. Thus, the studies of this grant examined the mechanism of action and the consequences of increased blood concentrations of free fatty acids on glucose metabolism in muscle and liver as well as blood flow of certain organs of the human body. Methods: The experimental protocols were performed by combining infusion of lipids with the application of new developed methods such as in vivo NMR spectroscopy, which makes it possible to exactly determine glucose uptake and disposal as glycogen directly without discomfort in cells of the human body. Results: The studies on skeletal muscle of the calf showed that even small increases in free fatty acid concentrations inhibit both the insulin stimulated as well as insulin independent, glucose uptake. These data support the novel hypothesis that free fatty acids do not need to be burned (oxidized) within cells before they affect glucose metabolism. Free fatty acids rather block glucose transport directly and rapidly and therefore lead to insulin resistance. The studies on the liver found that free fatty acids can induce an increase in blood glucose concentration in healthy humans, as long as the release of insulin by the pancreas is prevented. The increase in blood glucose levels is due to augmented synthesis of new glucose within the liver, but even more results from the effects of free fatty acids on muscle. Free fatty acids play also a role in the insulin resistance of patients with diabetes and/or impaired insulin release (partial agenesis of the pancreas). The studies on blood flow demonstrated that free fatty acids modulate blood flow of the eye and in the skin and that they impair blood vessel function. These changes are similar to that observed in patients with insulin resistance and /or type 2 diabetes. Conclusions: Taken together the studies provided evidence that free fatty acids play an important role in the development of insulin resistance and thereby in the pathogenesis of non-insulin dependent diabetes. Thus, the action of free fatty acids represents a target for novel concept for the treatment of diabetes.

Research institution(s)
  • Medizinische Universität Wien - 100%
Project participants
  • Werner Waldhäusl, Medizinische Universität Wien , associated research partner

Research Output

  • 1378 Citations
  • 13 Publications
Publications
  • 2003
    Title Direct and indirect effects of amino acids on hepatic glucose metabolism in humans
    DOI 10.1007/s00125-003-1129-1
    Type Journal Article
    Author Krebs M
    Journal Diabetologia
    Pages 917-925
    Link Publication
  • 2002
    Title Reduction of Plasma Leptin Concentrations by Arginine but Not Lipid Infusion in Humans
    DOI 10.1038/oby.2002.151
    Type Journal Article
    Author Stingl H
    Journal Obesity Research
    Pages 1111-1119
    Link Publication
  • 2002
    Title Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia
    DOI 10.2337/diabetes.51.1.49
    Type Journal Article
    Author Bischof M
    Journal Diabetes
    Pages 49-54
    Link Publication
  • 2001
    Title Effects of Short-Term Improvement of Insulin Treatment and Glycemia on Hepatic Glycogen Metabolism in Type 1 Diabetes
    DOI 10.2337/diabetes.50.2.392
    Type Journal Article
    Author Bischof M
    Journal Diabetes
    Pages 392-398
    Link Publication
  • 2001
    Title Glucose Metabolism in Pregnancy at High Altitude
    DOI 10.2337/diacare.24.5.817
    Type Journal Article
    Author Krampl E
    Journal Diabetes Care
    Pages 817-822
    Link Publication
  • 2000
    Title Elevated serum free fatty acid concentrations inhibit T lymphocyte signaling
    DOI 10.1096/fasebj.14.7.939
    Type Journal Article
    Author Stulnig T
    Journal The FASEB Journal
    Pages 939-947
  • 2004
    Title How Free Fatty Acids Inhibit Glucose Utilization in Human Skeletal Muscle
    DOI 10.1152/nips.01459.2003
    Type Journal Article
    Author Roden M
    Journal Physiology
    Pages 92-96
  • 2003
    Title Insulin-Dependent Modulation of Plasma Ghrelin and Leptin Concentrations Is Less Pronounced in Type 2 Diabetic Patients
    DOI 10.2337/diabetes.52.7.1792
    Type Journal Article
    Author Anderwald C
    Journal Diabetes
    Pages 1792-1798
    Link Publication
  • 2003
    Title Measurement of Fractional Whole-Body Gluconeogenesis in Humans From Blood Samples Using 2H Nuclear Magnetic Resonance Spectroscopy
    DOI 10.2337/diabetes.52.10.2475
    Type Journal Article
    Author Kunert O
    Journal Diabetes
    Pages 2475-2482
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF